title: Long-term follow-up results of patients with stage ic-iv ovarian-cancer treated with Cisplatin, epirubicin and Ifosfamide chemotherapy.
abstract: Sixty-three patients with stage Ic-IV ovarian cancer received cisplatin, epirubicin and ifosfamide chemotherapy following a staging surgery between 1985 and 1992. The optimal surgery (without macroscopic residual was completed in 44 patients including 12 stage III cases. A 5-year survival of 97.5% was obtained for the optimal cases; whereas that for suboptimal cases was only 24.0%. From the results, the regimen proved to be a promising adjuvant therapy for ovarian cancer after optimal surgery; moreover a need for a drastic amelioration of strategy is emphasized in the treatment of advanced ovarian cancer with extensive metastases.
authors: NATL KOKURA HOSP,DEPT OBSTET & GYNECOL,KITAKYUSHU,FUKUOKA,JAPAN.
authors: T
authors: T
authors: Nishida
authors: T
authors: T
authors: Oda
authors: T
authors: T
authors: Sugiyama
authors: A
authors: A
authors: Kataoka
authors: K
authors: K
authors: Ushijima
authors: M
authors: M
authors: Yakushiji